TIL Q3 2023 Earnings — Instil Bio, Inc. Revenue & Financial Results | Market Cap Arena

TILInstil Bio, Inc.

$62M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$67M

Net Income

-$67M

EPS (Diluted)

$-10.37

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$20M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$340M

Total Liabilities

$106M

Stockholders' Equity

$234M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$67M	-$57M	-17.8%
Net Income	-$67M	-$56M	-19.9%